<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>51(15)</volume><submitter>Di Santo R</submitter><pubmed_abstract>Novel quinolinonyl diketo acids were designed to obtain integrase (IN) inhibitors selectively active against the strand transfer (ST) step of the HIV integration process. Those new compounds are characterized by a single aryl diketo acid (DKA) chain in comparison to 4, a bifunctional diketo acid reported by our group as an anti-IN agent highly potent against both the 3'-processing and ST steps. Compound 6d was the most potent derivative in IN enzyme assays, while 6i showed the highest potency against HIV-1 in acutely infected cells. The selective inhibition of ST suggested the newly designed monofunctional DKAs bind the IN-DNA acceptor site without affecting the DNA donor site.</pubmed_abstract><journal>Journal of medicinal chemistry</journal><pagination>4744-50</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2646871</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities.</pubmed_title><pmcid>PMC2646871</pmcid><pubmed_authors>Roux A</pubmed_authors><pubmed_authors>Marchand C</pubmed_authors><pubmed_authors>Crucitti GC</pubmed_authors><pubmed_authors>Lavecchia A</pubmed_authors><pubmed_authors>Rosi F</pubmed_authors><pubmed_authors>Miele G</pubmed_authors><pubmed_authors>Galluzzo CM</pubmed_authors><pubmed_authors>Andreotti M</pubmed_authors><pubmed_authors>Iacovo A</pubmed_authors><pubmed_authors>Marinelli L</pubmed_authors><pubmed_authors>Novellino E</pubmed_authors><pubmed_authors>Palmisano L</pubmed_authors><pubmed_authors>Pommier Y</pubmed_authors><pubmed_authors>Di Giovanni C</pubmed_authors><pubmed_authors>Palamara AT</pubmed_authors><pubmed_authors>Costi R</pubmed_authors><pubmed_authors>Di Santo R</pubmed_authors><pubmed_authors>Amici R</pubmed_authors><pubmed_authors>Nencioni L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities.</name><description>Novel quinolinonyl diketo acids were designed to obtain integrase (IN) inhibitors selectively active against the strand transfer (ST) step of the HIV integration process. Those new compounds are characterized by a single aryl diketo acid (DKA) chain in comparison to 4, a bifunctional diketo acid reported by our group as an anti-IN agent highly potent against both the 3'-processing and ST steps. Compound 6d was the most potent derivative in IN enzyme assays, while 6i showed the highest potency against HIV-1 in acutely infected cells. The selective inhibition of ST suggested the newly designed monofunctional DKAs bind the IN-DNA acceptor site without affecting the DNA donor site.</description><dates><release>2008-01-01T00:00:00Z</release><publication>2008 Aug</publication><modification>2025-04-04T07:58:19.38Z</modification><creation>2019-03-27T00:20:52Z</creation></dates><accession>S-EPMC2646871</accession><cross_references><pubmed>18646746</pubmed><doi>10.1021/jm8001422</doi></cross_references></HashMap>